ASL Analytical is a newly formed company with the objective to develop and market a noninvasive blood glucose monitor.  The basis of this monitoring technology is transmission near infrared spectroscopy through a section of human skin.  In addition to glucose, this near infrared sensing technology will be capable of monitoring other metabolites, including lactate, urea, ethanol, and other endogenous substances present at millimolar concentrations in the interstitial fluid of skin.  Potential applications include the management of diabetes, evaluation of trauma or physical exertion, optimization of hemodialysis, and control of alcoholism and alcohol abuse.  The goal is to develop accurate noninvasive sensing technology that can operate under poorly controlled environmental conditions, such as home use by people with diabetes, spacecraft use by astronauts during long-term space flights, or battlefield use by paramedics for triage and life support purposes. 

News: ASL wins two-year, phase 1 grant STTR from National Institute of Diabetes and Digestive and Kidney Diseases.

Iowa Today, Nov., 3rd, 2007

The Daily Iowan, Nov., 1st, 2007

Corridor Business Journal, Nov., 5th, 2007